CRISPR-like technique offers clues to mimic protective genetic mutations
Using a variation of CRISPR gene editing may be a potential strategy for mimicking the protective effects of a genetic mutation linked to lower cholesterol levels and heart disease risks, according to new mouse research from the Perelman School of Medicine at the University of Pennsylvania published this week in Circulation.
People with naturally occurring mutations that cause a loss of function in the gene for ANGPTL3 have reduced blood triglycerides, LDL cholesterol, and risk of coronary heart disease, with no apparent detrimental consequences to their health. This makes the ANGPTL3 protein an attractive target for new heart disease drugs. Earlier studies at Penn found that single copies of inactivating mutations in ANGPTL3 are found in about one in every 250 people of European heritage; however, people with mutations in both copies of the gene are more rare.
A team led by Kiran Musunuru, MD, PhD, MPH, an associate professor of Cardiovascular Medicine, assessed in a mouse model whether base editing – a variation of CRISPR genome editing that does not require breaks in the double-strand of DNA – might be used in humans one day to introduce mutations into ANGPTL3 to reduce blood lipid levels.
“This proof-of-principle study showed that base-editing of ANGPTL3 is a potential way to permanently treat patients with harmful blood lipid levels,” Musunuru said. “It would be especially useful in patients with a rare condition called homozygous familial hypercholesterolemia, which causes sky-high cholesterol levels and dramatically increased risk of heart attack. They are very difficult to treat with today’s medications, and a one-time CRISPR ‘vaccination’ might be ready to use in these patients within five years.”
The study took a three-part approach. First, the team injected normal mice with the base-editing treatment for the ANGPTL3 gene. After a week, sequencing of the ANGPTL3 target site in liver samples from the mice revealed a median 35 percent editing rate in the target gene and no off-target mutations. In addition, the mean levels of blood lipids were significantly lower in the treated mice by up to 30 percent compared to untreated mice.
Second, the researchers compared mice with the modified ANGPTL3 gene to those injected with a base-editing treatment for another liver gene, PCSK9, for plasma cholesterol and triglycerides. After a week, ANGPTL3 targeting caused a similar reduction in cholesterol but a much greater decline in triglycerides compared to targeting PCSK9. The PCSK9 protein is the target of currently available medications, including evinacumab, which has been shown to reduce cholesterol (but not triglycerides) as well as the risk of heart attack and stroke.
Third, they looked at how base editing of the ANGPTL3 gene performed in a mouse model of homozygous familial hypercholesterolemia (in which knocking out PCSK9 had little effect). After two weeks, the treated mice showed substantially reduced triglycerides (56 percent) and cholesterol (51 percent) compared to untreated mice.
Musunuru’s lab is now preparing to test CRISPR-based treatments against the human ANGPTL3 gene in human liver cells transplanted into mice. This will provide important information on efficacy and safety that will be needed before human trials can move forward.
The Latest on: Gene editing
- Landmark research creates “universal” stem cells using CRISPR gene editing on February 18, 2019 at 6:00 pm
In an incredible milestone, scientists have for the first time created "universal" stem cells by using CRISPR gene-editing technology to produce pluripotent stem cells that can be transplanted ... […]
- Gene Editing and Sequencing Industry Hikes with Striking at a 22.5% CAGR by 2023 Briefing by Segmentation, Technology and Trend on February 18, 2019 at 5:40 pm
Feb 18, 2019 (MarketersMedia via COMTEX) -- Genotyping Market increasing research and development (R&D) activities in the healthcare sector and the rising prevalence of genetic ailments. Pune, India - ... […]
- 2019: CRISPR and therapeutic gene editing comes of age on February 18, 2019 at 4:31 pm
The furore that accompanied the news that Chinese scientist He Jiankui had carried out gene-editing on twin girls threatens to overshadow the strides forward being made by biopharma companies developi... […]
- Gene-editing kit puts power of lab into hands of citizen scientists on February 18, 2019 at 12:05 pm
OAKLAND — In an ordinary house tucked away on a quiet street in Oakland, Josiah Zayner stands over a container filled with green tree frogs with a syringe in hand. He carefully injects a liquid into a ... […]
- CRISPR gene editing makes stem cells 'invisible' to immune system on February 18, 2019 at 8:06 am
UC San Francisco scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally "invisible" to the immune system, a feat of biological ... […]
- Following Gene-Editing Scandal That Sparked Worldwide Outrage, WHO To Develop Global Ethics Standards For The Tech on February 15, 2019 at 5:44 am
Chinese scientist He Jiankui shocked the world when he announced that he'd used gene-editing technology on human embroyos--crossing a line that many had looked at as uncrossable in terms of ethics. […]
- Future of gene editing in limbo on February 14, 2019 at 8:00 am
In one version of the future, beef and dairy animals are disease-free, fruits and vegetables are resistant to viruses, potatoes taste better and last longer, and wheat has no gluten or allergenic prop... […]
- Gene Editing: The Present And Future on February 13, 2019 at 8:42 am
The U.S. is approaching human gene editing with more caution, while scientists in China are racing to experiment with gene editing. What are the latest progress and the social and ethical implications ... […]
- Why Gene Editing May Hold the Promise of a Herpes Cure on February 12, 2019 at 12:51 pm
Herpes is shockingly common. Recent estimates suggest at least half of all Americans have HSV-1, or oral herpes, which usually manifests as cold sores on or around one’s mouth, but can spread to someo... […]
- Many people are confused and concerned about human gene editing. They might just need a ‘better understanding’ of how it works on February 12, 2019 at 5:56 am
Google “CRISPR” and headlines touting “designer babies,” “ human rights,” and “bioethics” are more likely to come up than descriptions of how researchers are actually using the ... […]
via Google News and Bing News